Additional information Supplementary Information accompanies the paper on the Neuropsychopharmacology website Supplementary information Rights and permissions About this article Cite this article Harasta, A., Power, J., von Jonquieres, G
Lilly markets tirzepatide as Mounjaro to people with Type 2 diabetes, while Novo Nordisk does the same for semaglutide as Ozempic.) The results have not yet been peer-reviewed
She specializes in all things health and wellness, particularly dietary supplements and nutrition
Hendrickson RG, Bizovi KE
Staying Ahead of the Change The companies and brands that innovate in anticipation of the impact of these drugs will find themselves awash in new interest from those who feel a new sense of control and autonomy in their choices: brands that speak to their aspirational selves, affirm their commitments to living better, and underscore that behavior-modifying medications are only step one of a lifelong shift that includes their category and brand
Then you know youve reached a point where nothing seems to be able to keep you going